Role of dopamine in prepulse inhibition of acoustic startle

Prepulse inhibition of acoustic startle is the reduction in startle response to an intense auditory stimulus when this stimulus is immediately preceded by a weaker prestimulus. Prepulse inhibition occurs normally in humans and experimental animals, but schizophrenic persons often exhibit a marked im...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychopharmacologia 2000-04, Vol.149 (2), p.181-188
Hauptverfasser: JIANHUA ZHANG, FORKSTAM, C, ENGEL, J. A, SVENSSON, L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 188
container_issue 2
container_start_page 181
container_title Psychopharmacologia
container_volume 149
creator JIANHUA ZHANG
FORKSTAM, C
ENGEL, J. A
SVENSSON, L
description Prepulse inhibition of acoustic startle is the reduction in startle response to an intense auditory stimulus when this stimulus is immediately preceded by a weaker prestimulus. Prepulse inhibition occurs normally in humans and experimental animals, but schizophrenic persons often exhibit a marked impairment in this measure. Previous studies have shown that dopamine (DA)-dependent neuronal mechanisms are involved in the modulation of prepulse inhibition. Experiments were conducted in rats to elucidate further the involvement of DA-ergic mechanisms in prepulse inhibition. In line with previous studies, the indirect DA agonist, amphetamine, was shown to decrease prepulse inhibition. A close reverse relationship over time between DA overflow in the nucleus accumbens and prepulse inhibition was obtained using a technique allowing concomitant measurement of these parameters in awake, freely moving rats. This effect was more pronounced in amphetamine-treated rats compared to rats treated with equimolar doses of cocaine, which increased DA overflow without affecting prepulse inhibition. In other experiments, the combined treatment with subthreshold doses of the selective DA D1 agonist, SKF 38393, and the selective DA D2 agonist, quinpirole, was also shown to decrease prepulse inhibition. Finally, the selective DA D2 antagonist, raclopride, was shown to enhance prepulse inhibition. In line with previous studies, it is concluded that DA neurotransmission is involved in the modulation of prepulse inhibition and that the ventral part of the mesostriatal DA system may serve an important role in this modulation. Furthermore, the possibility is discussed that the discrepant results on prepulse inhibition obtained with amphetamine and cocaine may disclose functionally relevant differences in their mechanisms of action, and that the enhancement of prepulse inhibition induced by some antipsychotics in rats may reflect their propensity to induce adverse mental effects in humans.
doi_str_mv 10.1007/s002130000369
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17531640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3117810733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-bbaa770f088465aad6440791962a1956a78b9195b5c760cb3ee2f9b6cf15da2d3</originalsourceid><addsrcrecordid>eNpd0EtLxDAQB_Agiq6rR69SULxVM82zeJLFFywIoueSpClmaZuatAe_vSm74COXyQw_huGP0Bnga8BY3ESMCyA4PcLLPbQASoq8wKLYR4s0IzkBJo_QcYybGVFJD9ERYIkZB7pAt6--tZlvstoPqnO9zVyfDcEOUxvn_4fTbnS-n4kyfoqjM1kcVRhbe4IOGpXY6a4u0fvD_dvqKV-_PD6v7ta5IUKMudZKCYEbLCXlTKmaU4pFCSUvFJSMKyF16phmRnBsNLG2aErNTQOsVkVNluhqu3cI_nOycaw6F41tW9XbdFEFghHgFCd48Q9u_BT6dFtFAIQELAhJKt8qE3yMwTbVEFynwlcFuJozrf5kmvz5buukO1v_0tsQE7jcARWNapugeuPijyOUEwnkGwAre-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3117810733</pqid></control><display><type>article</type><title>Role of dopamine in prepulse inhibition of acoustic startle</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>JIANHUA ZHANG ; FORKSTAM, C ; ENGEL, J. A ; SVENSSON, L</creator><creatorcontrib>JIANHUA ZHANG ; FORKSTAM, C ; ENGEL, J. A ; SVENSSON, L</creatorcontrib><description>Prepulse inhibition of acoustic startle is the reduction in startle response to an intense auditory stimulus when this stimulus is immediately preceded by a weaker prestimulus. Prepulse inhibition occurs normally in humans and experimental animals, but schizophrenic persons often exhibit a marked impairment in this measure. Previous studies have shown that dopamine (DA)-dependent neuronal mechanisms are involved in the modulation of prepulse inhibition. Experiments were conducted in rats to elucidate further the involvement of DA-ergic mechanisms in prepulse inhibition. In line with previous studies, the indirect DA agonist, amphetamine, was shown to decrease prepulse inhibition. A close reverse relationship over time between DA overflow in the nucleus accumbens and prepulse inhibition was obtained using a technique allowing concomitant measurement of these parameters in awake, freely moving rats. This effect was more pronounced in amphetamine-treated rats compared to rats treated with equimolar doses of cocaine, which increased DA overflow without affecting prepulse inhibition. In other experiments, the combined treatment with subthreshold doses of the selective DA D1 agonist, SKF 38393, and the selective DA D2 agonist, quinpirole, was also shown to decrease prepulse inhibition. Finally, the selective DA D2 antagonist, raclopride, was shown to enhance prepulse inhibition. In line with previous studies, it is concluded that DA neurotransmission is involved in the modulation of prepulse inhibition and that the ventral part of the mesostriatal DA system may serve an important role in this modulation. Furthermore, the possibility is discussed that the discrepant results on prepulse inhibition obtained with amphetamine and cocaine may disclose functionally relevant differences in their mechanisms of action, and that the enhancement of prepulse inhibition induced by some antipsychotics in rats may reflect their propensity to induce adverse mental effects in humans.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s002130000369</identifier><identifier>PMID: 10805614</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology ; Acoustic Stimulation ; Agonists ; Amphetamine - pharmacology ; Amphetamines ; Analysis of Variance ; Animals ; Antipsychotics ; Biological and medical sciences ; Catecholaminergic system ; Cocaine ; Cocaine - pharmacology ; Dopamine ; Dopamine - physiology ; Dopamine Agonists - pharmacology ; Dopamine Antagonists - pharmacology ; Dopamine D1 receptors ; Dopamine D2 Receptor Antagonists ; Dopamine D2 receptors ; Male ; Medical sciences ; Neuromodulation ; Neuropharmacology ; Neurotransmission ; Neurotransmitters. Neurotransmission. Receptors ; Noise ; Nucleus accumbens ; Pharmacology. Drug treatments ; Quinpirole ; Quinpirole - pharmacology ; Raclopride ; Raclopride - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Dopamine D1 - agonists ; Receptors, Dopamine D1 - metabolism ; Receptors, Dopamine D2 - agonists ; Receptors, Dopamine D2 - metabolism ; Reflex, Startle - drug effects ; Reflex, Startle - physiology ; Startle response</subject><ispartof>Psychopharmacologia, 2000-04, Vol.149 (2), p.181-188</ispartof><rights>2000 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 2000.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-bbaa770f088465aad6440791962a1956a78b9195b5c760cb3ee2f9b6cf15da2d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1346381$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10805614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JIANHUA ZHANG</creatorcontrib><creatorcontrib>FORKSTAM, C</creatorcontrib><creatorcontrib>ENGEL, J. A</creatorcontrib><creatorcontrib>SVENSSON, L</creatorcontrib><title>Role of dopamine in prepulse inhibition of acoustic startle</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>Prepulse inhibition of acoustic startle is the reduction in startle response to an intense auditory stimulus when this stimulus is immediately preceded by a weaker prestimulus. Prepulse inhibition occurs normally in humans and experimental animals, but schizophrenic persons often exhibit a marked impairment in this measure. Previous studies have shown that dopamine (DA)-dependent neuronal mechanisms are involved in the modulation of prepulse inhibition. Experiments were conducted in rats to elucidate further the involvement of DA-ergic mechanisms in prepulse inhibition. In line with previous studies, the indirect DA agonist, amphetamine, was shown to decrease prepulse inhibition. A close reverse relationship over time between DA overflow in the nucleus accumbens and prepulse inhibition was obtained using a technique allowing concomitant measurement of these parameters in awake, freely moving rats. This effect was more pronounced in amphetamine-treated rats compared to rats treated with equimolar doses of cocaine, which increased DA overflow without affecting prepulse inhibition. In other experiments, the combined treatment with subthreshold doses of the selective DA D1 agonist, SKF 38393, and the selective DA D2 agonist, quinpirole, was also shown to decrease prepulse inhibition. Finally, the selective DA D2 antagonist, raclopride, was shown to enhance prepulse inhibition. In line with previous studies, it is concluded that DA neurotransmission is involved in the modulation of prepulse inhibition and that the ventral part of the mesostriatal DA system may serve an important role in this modulation. Furthermore, the possibility is discussed that the discrepant results on prepulse inhibition obtained with amphetamine and cocaine may disclose functionally relevant differences in their mechanisms of action, and that the enhancement of prepulse inhibition induced by some antipsychotics in rats may reflect their propensity to induce adverse mental effects in humans.</description><subject>2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology</subject><subject>Acoustic Stimulation</subject><subject>Agonists</subject><subject>Amphetamine - pharmacology</subject><subject>Amphetamines</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Antipsychotics</subject><subject>Biological and medical sciences</subject><subject>Catecholaminergic system</subject><subject>Cocaine</subject><subject>Cocaine - pharmacology</subject><subject>Dopamine</subject><subject>Dopamine - physiology</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Dopamine D1 receptors</subject><subject>Dopamine D2 Receptor Antagonists</subject><subject>Dopamine D2 receptors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuromodulation</subject><subject>Neuropharmacology</subject><subject>Neurotransmission</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Noise</subject><subject>Nucleus accumbens</subject><subject>Pharmacology. Drug treatments</subject><subject>Quinpirole</subject><subject>Quinpirole - pharmacology</subject><subject>Raclopride</subject><subject>Raclopride - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Dopamine D1 - agonists</subject><subject>Receptors, Dopamine D1 - metabolism</subject><subject>Receptors, Dopamine D2 - agonists</subject><subject>Receptors, Dopamine D2 - metabolism</subject><subject>Reflex, Startle - drug effects</subject><subject>Reflex, Startle - physiology</subject><subject>Startle response</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpd0EtLxDAQB_Agiq6rR69SULxVM82zeJLFFywIoueSpClmaZuatAe_vSm74COXyQw_huGP0Bnga8BY3ESMCyA4PcLLPbQASoq8wKLYR4s0IzkBJo_QcYybGVFJD9ERYIkZB7pAt6--tZlvstoPqnO9zVyfDcEOUxvn_4fTbnS-n4kyfoqjM1kcVRhbe4IOGpXY6a4u0fvD_dvqKV-_PD6v7ta5IUKMudZKCYEbLCXlTKmaU4pFCSUvFJSMKyF16phmRnBsNLG2aErNTQOsVkVNluhqu3cI_nOycaw6F41tW9XbdFEFghHgFCd48Q9u_BT6dFtFAIQELAhJKt8qE3yMwTbVEFynwlcFuJozrf5kmvz5buukO1v_0tsQE7jcARWNapugeuPijyOUEwnkGwAre-A</recordid><startdate>20000401</startdate><enddate>20000401</enddate><creator>JIANHUA ZHANG</creator><creator>FORKSTAM, C</creator><creator>ENGEL, J. A</creator><creator>SVENSSON, L</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20000401</creationdate><title>Role of dopamine in prepulse inhibition of acoustic startle</title><author>JIANHUA ZHANG ; FORKSTAM, C ; ENGEL, J. A ; SVENSSON, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-bbaa770f088465aad6440791962a1956a78b9195b5c760cb3ee2f9b6cf15da2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology</topic><topic>Acoustic Stimulation</topic><topic>Agonists</topic><topic>Amphetamine - pharmacology</topic><topic>Amphetamines</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Antipsychotics</topic><topic>Biological and medical sciences</topic><topic>Catecholaminergic system</topic><topic>Cocaine</topic><topic>Cocaine - pharmacology</topic><topic>Dopamine</topic><topic>Dopamine - physiology</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Dopamine D1 receptors</topic><topic>Dopamine D2 Receptor Antagonists</topic><topic>Dopamine D2 receptors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuromodulation</topic><topic>Neuropharmacology</topic><topic>Neurotransmission</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Noise</topic><topic>Nucleus accumbens</topic><topic>Pharmacology. Drug treatments</topic><topic>Quinpirole</topic><topic>Quinpirole - pharmacology</topic><topic>Raclopride</topic><topic>Raclopride - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Dopamine D1 - agonists</topic><topic>Receptors, Dopamine D1 - metabolism</topic><topic>Receptors, Dopamine D2 - agonists</topic><topic>Receptors, Dopamine D2 - metabolism</topic><topic>Reflex, Startle - drug effects</topic><topic>Reflex, Startle - physiology</topic><topic>Startle response</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JIANHUA ZHANG</creatorcontrib><creatorcontrib>FORKSTAM, C</creatorcontrib><creatorcontrib>ENGEL, J. A</creatorcontrib><creatorcontrib>SVENSSON, L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JIANHUA ZHANG</au><au>FORKSTAM, C</au><au>ENGEL, J. A</au><au>SVENSSON, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of dopamine in prepulse inhibition of acoustic startle</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2000-04-01</date><risdate>2000</risdate><volume>149</volume><issue>2</issue><spage>181</spage><epage>188</epage><pages>181-188</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>Prepulse inhibition of acoustic startle is the reduction in startle response to an intense auditory stimulus when this stimulus is immediately preceded by a weaker prestimulus. Prepulse inhibition occurs normally in humans and experimental animals, but schizophrenic persons often exhibit a marked impairment in this measure. Previous studies have shown that dopamine (DA)-dependent neuronal mechanisms are involved in the modulation of prepulse inhibition. Experiments were conducted in rats to elucidate further the involvement of DA-ergic mechanisms in prepulse inhibition. In line with previous studies, the indirect DA agonist, amphetamine, was shown to decrease prepulse inhibition. A close reverse relationship over time between DA overflow in the nucleus accumbens and prepulse inhibition was obtained using a technique allowing concomitant measurement of these parameters in awake, freely moving rats. This effect was more pronounced in amphetamine-treated rats compared to rats treated with equimolar doses of cocaine, which increased DA overflow without affecting prepulse inhibition. In other experiments, the combined treatment with subthreshold doses of the selective DA D1 agonist, SKF 38393, and the selective DA D2 agonist, quinpirole, was also shown to decrease prepulse inhibition. Finally, the selective DA D2 antagonist, raclopride, was shown to enhance prepulse inhibition. In line with previous studies, it is concluded that DA neurotransmission is involved in the modulation of prepulse inhibition and that the ventral part of the mesostriatal DA system may serve an important role in this modulation. Furthermore, the possibility is discussed that the discrepant results on prepulse inhibition obtained with amphetamine and cocaine may disclose functionally relevant differences in their mechanisms of action, and that the enhancement of prepulse inhibition induced by some antipsychotics in rats may reflect their propensity to induce adverse mental effects in humans.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>10805614</pmid><doi>10.1007/s002130000369</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0033-3158
ispartof Psychopharmacologia, 2000-04, Vol.149 (2), p.181-188
issn 0033-3158
1432-2072
language eng
recordid cdi_proquest_miscellaneous_17531640
source MEDLINE; Springer Nature - Complete Springer Journals
subjects 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology
Acoustic Stimulation
Agonists
Amphetamine - pharmacology
Amphetamines
Analysis of Variance
Animals
Antipsychotics
Biological and medical sciences
Catecholaminergic system
Cocaine
Cocaine - pharmacology
Dopamine
Dopamine - physiology
Dopamine Agonists - pharmacology
Dopamine Antagonists - pharmacology
Dopamine D1 receptors
Dopamine D2 Receptor Antagonists
Dopamine D2 receptors
Male
Medical sciences
Neuromodulation
Neuropharmacology
Neurotransmission
Neurotransmitters. Neurotransmission. Receptors
Noise
Nucleus accumbens
Pharmacology. Drug treatments
Quinpirole
Quinpirole - pharmacology
Raclopride
Raclopride - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Dopamine D1 - agonists
Receptors, Dopamine D1 - metabolism
Receptors, Dopamine D2 - agonists
Receptors, Dopamine D2 - metabolism
Reflex, Startle - drug effects
Reflex, Startle - physiology
Startle response
title Role of dopamine in prepulse inhibition of acoustic startle
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T08%3A32%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20dopamine%20in%20prepulse%20inhibition%20of%20acoustic%20startle&rft.jtitle=Psychopharmacologia&rft.au=JIANHUA%20ZHANG&rft.date=2000-04-01&rft.volume=149&rft.issue=2&rft.spage=181&rft.epage=188&rft.pages=181-188&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/s002130000369&rft_dat=%3Cproquest_cross%3E3117810733%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3117810733&rft_id=info:pmid/10805614&rfr_iscdi=true